Lennartz, Frank
Brod, Florian
Dabbs, Rebecca
Miura, Kazutoyo
Mekhaiel, David
Marini, Arianna
Jore, Matthijs M.
Søgaard, Max M.
Jørgensen, Thomas
de Jongh, Willem A.
Sauerwein, Robert W.
Long, Carole A.
Biswas, Sumi http://orcid.org/0000-0001-8507-7282
Higgins, Matthew K. http://orcid.org/0000-0002-2870-1955
Funding for this research was provided by:
Wellcome Trust (101020/Z/13/Z)
Article History
Received: 4 June 2018
Accepted: 29 August 2018
First Online: 20 September 2018
Competing interests
: M.M.S., T.J. and W.A.d.J. are employees of and W.A.d.J. is a shareholder in ExpreS<sup>2</sup>ion Biotechnologies, which has developed and is marketing the ExpreS<sup>2</sup> cell expression platform. The remaining authors declare no competing interests.